Smartphone Training for Attention Regulation for IBS
Key facts
- Who runs it
- Carnegie Mellon University
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 359 people enrolled
- Started
- 1 Mar 2022
- Ended
- 14 Feb 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Mindfulness and Attention Training
- Mindfulness training
- Coping Condition
- Record updated
- 26 March 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Rome IV IBS diagnosis
- Indicate moderate to high levels of psychological distress over the past two weeks (composite score >=4 on the Patient Health Questionnaire-4)
- Willingness to provide assessments of bowel symptoms and complete study measures (including smartphone assessments)
- Willingness/availability to be randomized and participate in all study activities
Who cannot take part
- Begun any new treatments for IBS in the four weeks prior to baseline
- Report a new diagnosis of a (non-acute) medical or psychiatric condition requiring treatment within the last 3 months
- Have a history of diagnosed IBD or gastrointestinal malignancies
- CGI Interview Only: Is a patient of Dr. David Levinthal; Cold Challenge Sub-study. Exclusion criteria: an existing pain condition, Reynaud's disease, history of heart/cardiovascular disease, high blood pressure, recent injuries, circulatory disorders, current or past frostbite, open cuts, or sores in both hands, a history of seizures, asthma, sickle cell disease or trait, cerebrovascular disease, a recent stroke or heart attack, or anxiolytic medication (e.g., Ativan, Xanax) or pain medication (e.g., aspirin) taken in the 2 hours prior to the study, pregnant or might be pregnant, and/or have a tendency/history of fainting after vaccines, shots, and/or blood draws. Participants will be excluded if they have taken anxiolytic medication (e.g., Ativan, Xanax) or pain medication (e.g., aspirin) taken in the 2 hours prior to the lab session. Participants who report viral illness (e.g., cold) and/or negative physical health symptoms (e.g., stomachache, nausea, fever, dehydration, hunger, sleep deprivation) before the start of the session will also be excluded; As they will be visiting our laboratory on campus, participants will now be required to show proof of COVID-19 vaccination to participate in the study. Participants must also show proof of a booster shot, if they do not have one, they will be asked to wear a mask at in-person sessions to participate. Moving forward, we will continue to follow CMU COVID protocols
- Non-English speaking
- Currently pregnant
- Had a colonoscopy within 2 weeks of enrolling in the study or within the first 4 weeks of study procedures
Where in United States
- Carnegie Mellon UniversityPittsburgh, United States
About the trial
What the trial wants to find out
In the largest and most well-controlled randomized control trial of mindfulness-based interventions (MBIs) training in irritable bowel syndrome (IBS) to-date (N=360), the investigators will evaluate whether a smartphone MBI program (with attention monitoring and acceptance skills training; Monitor+Accept, MA-MBI) reduces daily life stress and IBS symptoms at post-treatment and two-month follow-up, relative to a matched MBI program with acceptance skills training removed (training in attention monitoring skills only; Monitor Only, MO-MBI) or to an active stress management training control group (Coping Control, CC). Participants will not only provide clinician and patient assessed measures of IBS symptoms at the three time points, but they will also provide sensitive experience sampling assessments (using Ecological Momentary Assessment) of their stress and symptoms in daily life at each time point. Finally, as an exploratory aim, participants will provide stool samples at baseline and post-intervention to provide the first ever test of whether MBIs can alter the gut microbiome in IBS. We will also conduct a sub-study that will include completion of a cold-water challenge performance task to test individuals' distress tolerance.
The 3 groups in the trial
- Monitor & Accept (MA-MBI)Existing treatment, for comparison
14-day smartphone based mindfulness meditation attention monitoring and acceptance skills training intervention consisting of a 5-minute introductory video, a 20-minute audio-guided lesson, plus daily life homework practice (3-10 minutes) each day.
Treatment: Mindfulness and Attention Training
- Monitor Only (MO-MBI)Existing treatment, for comparison
14-day smartphone based mindfulness meditation training intervention consisting of a 5-minute introductory video, a 20-minute audio-guided lesson, plus daily life homework practice (3-10 minutes) each day.
Treatment: Mindfulness training
- Coping Condition (CC)Existing treatment, for comparison
14-day smartphone based training intervention focused on coping strategies consisting of a 5-minute introductory video, a 20-minute audio-guided lesson, plus daily life homework practice (3-10 minutes) each day.
Treatment: Coping Condition
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Smartphone Stress Management Training for Irritable Bowel Syndrome
- Record updated
- 26 March 2025